The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J. M.
Right arrow Articles by Oppenheim, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J. M.
Right arrow Articles by Oppenheim, J. J.
The Journal of Immunology, 1998, 161: 4309-4317.
Copyright © 1998 by The American Association of Immunologists

HIV-1 Envelope gp120 Inhibits the Monocyte Response to Chemokines Through CD4 Signal-Dependent Chemokine Receptor Down-Regulation1

Ji Ming Wang2,*, Hirotsugu Ueda*, O. M. Zack Howard{ddagger}, Michael C. Grimm*, Oleg Chertov{ddagger}, Xiaoqi Gong*, Wanghua Gong{ddagger}, James H. Resau, Christopher C. Broder||, Gerald Evans{ddagger}, Larry O. Arthur§, Francis W. Ruscetti{dagger} and Joost J. Oppenheim*

Laboratories of * Molecular Immunoregulation and {dagger} Leukocyte Biology, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, {ddagger} Intramural Research Support Program and § AIDS Vaccine Program, SAIC Frederick, and Advanced BioScience Laboratories-Basic Research Program, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD 21702; and || Uniformed Services University of the Health Sciences, Bethesda, MD 20814

Since HIV-1 infection results in severe immunosuppression, and the envelope protein gp120 has been reported to interact with some of the chemokine receptors on human T lymphocytes, we postulated that gp120 may also affect monocyte activation by a variety of chemokines. This study shows that human peripheral blood monocytes when preincubated with gp120 either purified from laboratory-adapted strains or as recombinant proteins exhibited markedly reduced binding, calcium mobilization, and chemotactic response to chemokines. The gp-120-pretreated monocytes also showed a decreased response to FMLP. This broad inhibition of monocyte activation by chemoattractants required interaction of gp120 with CD4, since the effect of gp120 was only observed in CD4+ monocytes and in HEK 293 cells only if cotransfected with both chemokine receptors and an intact CD4, but not a CD4 lacking its cytoplasmic domain. Anti-CD4 mAbs mimicked the effect of gp120, and both anti-CD4 Ab and gp120 caused internalization of CXCR4 in HEK 293 cells provided they also expressed CD4. Staurosporine blocked the inhibitory effect of gp120 on monocytes, suggesting that cellular signaling was required for gp120 to inhibit the response of CD4+ cells to chemoattractants. Our study demonstrates a broad suppressive effect of gp120 on monocyte activation by chemoattractants through the down-regulation of cell surface receptors. Thus, gp120 may be used by HIV-1 to disarm the monocyte response to inflammatory stimulation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Malik, Y.-Y. Chen, M. F. Kienzle, B. E. Tomkowicz, R. G. Collman, and A. Ptasznik
Monocyte Migration and LFA-1-Mediated Attachment to Brain Microvascular Endothelia Is Regulated by SDF-1{alpha} through Lyn Kinase
J. Immunol., October 1, 2008; 181(7): 4632 - 4637.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Karlsson, J.-C. Grivel, S. S. Chen, A. Karlsson, J. Albert, E. M. Fenyo, and L. B. Margolis
Differential Pathogenesis of Primary CCR5-Using Human Immunodeficiency Virus Type 1 Isolates in Ex Vivo Human Lymphoid Tissue
J. Virol., September 1, 2005; 79(17): 11151 - 11160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard
HIV Type 1 Glycoprotein 120 Inhibits Human B Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 12, CC Chemokine Ligand (CCL)20, and CCL21
J. Immunol., July 1, 2005; 175(1): 302 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. K. Choudhary, N. R. Choudhary, K. C. Kimbrell, J. Colasanti, A. Ziogas, D. Kwa, H. Schuitemaker, and D. Camerini
R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression
J. Virol., January 1, 2005; 79(1): 458 - 471.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Z. Fernandis, R. P. Cherla, R. D. Chernock, and R. K. Ganju
CXCR4/CCR5 Down-modulation and Chemotaxis Are Regulated by the Proteasome Pathway
J. Biol. Chem., May 10, 2002; 277(20): 18111 - 18117.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Van Drenth, A. Jenkins, L. Ledwich, T. C. Ryan, M. V. Mashikian, W. Brazer, D. M. Center, and W. W. Cruikshank
Desensitization of CXC Chemokine Receptor 4, Mediated by IL-16/CD4, Is Independent of p56lck Enzymatic Activity
J. Immunol., December 1, 2000; 165(11): 6356 - 6363.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. V. Mashikian, T. C. Ryan, A. Seman, W. Brazer, D. M. Center, and W. W. Cruikshank
Reciprocal Desensitization of CCR5 and CD4 Is Mediated by IL-16 and Macrophage-Inflammatory Protein-1{beta}, Respectively
J. Immunol., September 15, 1999; 163(6): 3123 - 3130.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. M. Wang and J. J. Oppenheim
Interference with the Signaling Capacity of CC Chemokine Receptor 5 Can Compromise Its Role as an HIV-1 Entry Coreceptor in Primary T Lymphocytes
J. Exp. Med., September 6, 1999; 190(5): 591 - 596.
[Full Text] [PDF]


Home page
BloodHome page
X. Deng, H. Ueda, S. B. Su, W. Gong, N. M. Dunlop, J.-L. Gao, P. M. Murphy, and J. M. Wang
A Synthetic Peptide Derived From Human Immunodeficiency Virus Type 1 gp120 Downregulates the Expression and Function of Chemokine Receptors CCR5 and CXCR4 in Monocytes by Activating the 7-Transmembrane G-Protein-Coupled Receptor FPRL1/LXA4R
Blood, August 15, 1999; 94(4): 1165 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Koedel, B. Kohleisen, B. Sporer, F. Lahrtz, V. Ovod, A. Fontana, V. Erfle, and H.-W. Pfister
HIV Type 1 Nef Protein Is a Viral Factor for Leukocyte Recruitment into the Central Nervous System
J. Immunol., August 1, 1999; 163(3): 1237 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Su, W. Gong, M. Grimm, I. Utsunomiya, R. Sargeant, J. J. Oppenheim, and J. Ming Wang
Inhibition of Tyrosine Kinase Activation Blocks the Down-Regulation of CXC Chemokine Receptor 4 by HIV-1 gp120 in CD4+ T Cells
J. Immunol., June 15, 1999; 162(12): 7128 - 7132.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. B. Su, W.-h. Gong, J.-L. Gao, W.-P. Shen, M. C. Grimm, X. Deng, P. M. Murphy, J. J. Oppenheim, and J. M. Wang
T20/DP178, an Ectodomain Peptide of Human Immunodeficiency Virus Type 1 gp41, Is an Activator of Human Phagocyte N-Formyl Peptide Receptor
Blood, June 1, 1999; 93(11): 3885 - 3892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Su, J.-l. Gao, W.-h. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang
T21/DP107, A Synthetic Leucine Zipper-Like Domain of the HIV-1 Envelope gp41, Attracts and Activates Human Phagocytes by Using G-Protein-Coupled Formyl Peptide Receptors
J. Immunol., May 15, 1999; 162(10): 5924 - 5930.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q.-H. Liu, D. A. Williams, C. McManus, F. Baribaud, R. W. Doms, D. Schols, E. De Clercq, M. I. Kotlikoff, R. G. Collman, and B. D. Freedman
HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation
PNAS, April 25, 2000; 97(9): 4832 - 4837.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.